Welcome to BioReagent Hub Hotline:19920083827

GBVAM as a Novel NHE1 Inhibitor Alleviates Doxorubicin-Induced Cardiotoxicity via PI3K/Akt…

More in this category

✉Email 💬Message 👤Member
↑Top